These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1514 related articles for article (PubMed ID: 29225343)

  • 61. Intravenous delivery of granulocyte-macrophage colony stimulating factor impairs survival in lipopolysaccharide-induced sepsis.
    Krebs J; Hillenbrand A; Tsagogiorgas C; Patry C; Tönshoff B; Yard B; Beck G; Rafat N
    PLoS One; 2019; 14(6):e0218602. PubMed ID: 31220157
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lipoxin A4 protects against lipopolysaccharide-induced sepsis by promoting innate response activator B cells generation.
    Cheng Q; Wang Z; Ma R; Chen Y; Yan Y; Miao S; Jiao J; Cheng X; Kong L; Ye D
    Int Immunopharmacol; 2016 Oct; 39():229-235. PubMed ID: 27494686
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.
    Santini SM; Lapenta C; Logozzi M; Parlato S; Spada M; Di Pucchio T; Belardelli F
    J Exp Med; 2000 May; 191(10):1777-88. PubMed ID: 10811870
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation.
    Fanning NF; Kell MR; Shorten GD; Kirwan WO; Bouchier-Hayes D; Cotter TG; Redmond HP
    Shock; 1999 Mar; 11(3):167-74. PubMed ID: 10188768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Granulocyte macrophage colony-stimulating factor improves survival in two models of gut-derived sepsis by improving gut barrier function and modulating bacterial clearance.
    Gennari R; Alexander JW; Gianotti L; Eaves-Pyles T; Hartmann S
    Ann Surg; 1994 Jul; 220(1):68-76. PubMed ID: 8024361
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Signaling of granulocyte macrophage colony stimulating factor and its clinical application: host-defense and organ protection].
    Uchida K
    Masui; 2013 Mar; 62(3):265-74. PubMed ID: 23544327
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Future uses of granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Jones TC
    Stem Cells; 1994; 12 Suppl 1():229-39; discussion 239-40. PubMed ID: 7696962
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanisms for T cell tolerance induced with granulocyte colony-stimulating factor.
    Yang JZ; Zhang JQ; Sun LX
    Mol Immunol; 2016 Feb; 70():56-62. PubMed ID: 26703218
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of immature myeloid Gr-1+ cells in the development of antitumor immunity.
    Li Q; Pan PY; Gu P; Xu D; Chen SH
    Cancer Res; 2004 Feb; 64(3):1130-9. PubMed ID: 14871848
    [TBL] [Abstract][Full Text] [Related]  

  • 70. What is the pathophysiology of the septic host upon admission?
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S2-5. PubMed ID: 21129934
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?
    Winkler MS; Rissiek A; Priefler M; Schwedhelm E; Robbe L; Bauer A; Zahrte C; Zoellner C; Kluge S; Nierhaus A
    PLoS One; 2017; 12(8):e0182427. PubMed ID: 28771573
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors.
    Griffin JD; Spertini O; Ernst TJ; Belvin MP; Levine HB; Kanakura Y; Tedder TF
    J Immunol; 1990 Jul; 145(2):576-84. PubMed ID: 1694883
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
    Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
    J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.
    Verkade MA; van de Wetering J; Klepper M; Vaessen LM; Weimar W; Betjes MG
    Kidney Int; 2004 Aug; 66(2):614-21. PubMed ID: 15253714
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.
    Shinoda K; Sugiyama E; Taki H; Harada S; Mino T; Maruyama M; Kobayashi M
    Bone; 2003 Oct; 33(4):711-20. PubMed ID: 14555277
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Beneficial effects of citrulline enteral administration on sepsis-induced T cell mitochondrial dysfunction.
    Reizine F; Grégoire M; Lesouhaitier M; Coirier V; Gauthier J; Delaloy C; Dessauge E; Creusat F; Uhel F; Gacouin A; Dessauge F; Le Naoures C; Moreau C; Bendavid C; Daniel Y; Petitjean K; Bordeau V; Lamaison C; Piau C; Cattoir V; Roussel M; Fromenty B; Michelet C; Le Tulzo Y; Zmijewski J; Thibault R; Cogné M; Tarte K; Tadié JM
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35173051
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells.
    Krug A; Rothenfusser S; Selinger S; Bock C; Kerkmann M; Battiany J; Sarris A; Giese T; Speiser D; Endres S; Hartmann G
    J Immunol; 2003 Apr; 170(7):3468-77. PubMed ID: 12646607
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Granulocyte macrophage-colony stimulating factor augmentation therapy in sepsis: is there a role?
    Trapnell BC
    Am J Respir Crit Care Med; 2002 Jul; 166(2):129-30. PubMed ID: 12119219
    [No Abstract]   [Full Text] [Related]  

  • 80. Immunosenescence: A Critical Factor Associated With Organ Injury After Sepsis.
    Lu X; Yang YM; Lu YQ
    Front Immunol; 2022; 13():917293. PubMed ID: 35924237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.